齐拉西酮盐酸盐一水合物

产品名称：

138982-67-9
Ziprasidone for system suitability 2
Ziprasidone Hydrochloride Monohydrate
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one Hydrochloride Monohydrate
CP-88059
Geodon
齐拉西酮
5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one 盐酸盐一水合物
齐拉西酮盐酸盐一水合物

产品介绍：

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

Ziprasidone is an atypical antipsychotic; FDA approved for the treatment of schizophrenia.

包装

Unit quantity: 0.465 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式	C₂₁H₂₁ClN₄OS · HCl · H₂O
分子量	467.41
MDL编号	MFCD00921885
PubChem化学物质编号	329831318
NACRES	NA.24

产品性质

等级	pharmaceutical primary standard
manufacturer/tradename	EDQM
application(s)	pharmaceutical (small molecule)
格式	neat
SMILES string	O.Cl.Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45
InChI	1S/C21H21ClN4OS.ClH.H2O/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21;;/h1-4,11,13H,5-10,12H2,(H,23,27);1H;1H2
InChI key	ZCBZSCBNOOIHFP-UHFFFAOYSA-N
Gene Information	human ... DRD2(1813), HTR2A(3356), HTR2C(3358)

安全信息

象形图
警示用语：	Warning
危险声明	H317 - H373
预防措施声明	P260 - P280
危险分类	Skin Sens. 1 - STOT RE 2 Oral
储存分类代码	13 - Non Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable